Yuan Wen, Xie Songping, Wang Meng, Pan Shan, Huang Xiaoxing, Xiong Meng, Xiao Rui-Jing, Xiong Jie, Zhang Qiu-Ping, Shao Liang
Department of Internal Medicine, Zhongnan Hospital of Wuhan University.
Department of Immunology, Basic School, Wuhan University.
Onco Targets Ther. 2018 Mar 23;11:1683-1695. doi: 10.2147/OTT.S149012. eCollection 2018.
ZWINT is a crucial component of the mitotic checkpoint. However, its possible role in lung cancer is unclear. In this study, we determined its correlation with lung cancer.
Real-time PCR and immunohistochemistry (IHC) were used to determine 40 collected clinical lung cancer samples. Chi-square test was used to examine possible correlations between ZWINT expression and clinicopathological factors. The prognostic significance of mRNA expression of ZWINT in lung cancer was evaluated using the Kaplan-Meier plotter. Univariate and multivariate Cox proportional hazards regression analysis were performed to determine whether ZWINT is an independent risk factor for overall survival (OS) and disease-free survival (DFS) of lung cancer patients. Additionally, STRING database was used to analyze protein-protein interactions.
In this study, we screened 13 GSE datasets and detected that ZWINT is highly expressed in multiple carcinomas including lung, melanoma, prostate, nasopharyngeal, gastric, pancreatic, colon, esophageal, ovarian, renal, breast and liver cancer. Real-time PCR and IHC results of collected clinical lung cancer samples confirmed that ZWINT is highly expressed in tumor tissues compared with adjacent non-tumor tissues. Additionally, high expression of ZWINT might predict poor OS and DFS in lung cancer patients. Moreover, disease stage and expression level of ZWINT were correlated with recurrence-free survival and OS in lung cancer. Analysis of protein-protein interaction based on STRING database gained 8 top genes which could interact with ZWINT, including , , , , , , , , and .
ZWINT is aberrantly highly expressed in lung tumor tissues and might be involved in the pathogenesis of lung cancer.
ZWINT是有丝分裂检查点的关键组成部分。然而,其在肺癌中的可能作用尚不清楚。在本研究中,我们确定了其与肺癌的相关性。
采用实时荧光定量PCR和免疫组织化学(IHC)检测40例收集的临床肺癌样本。采用卡方检验分析ZWINT表达与临床病理因素之间的可能相关性。使用Kaplan-Meier绘图仪评估ZWINT mRNA表达在肺癌中的预后意义。进行单因素和多因素Cox比例风险回归分析,以确定ZWINT是否为肺癌患者总生存期(OS)和无病生存期(DFS)的独立危险因素。此外,使用STRING数据库分析蛋白质-蛋白质相互作用。
在本研究中,我们筛选了13个GSE数据集,检测到ZWINT在包括肺癌、黑色素瘤、前列腺癌、鼻咽癌、胃癌、胰腺癌、结肠癌、食管癌、卵巢癌、肾癌、乳腺癌和肝癌在内的多种癌症中高表达。收集的临床肺癌样本的实时荧光定量PCR和IHC结果证实,与相邻非肿瘤组织相比,ZWINT在肿瘤组织中高表达。此外,ZWINT的高表达可能预示肺癌患者的OS和DFS较差。此外,疾病分期和ZWINT表达水平与肺癌的无复发生存期和OS相关。基于STRING数据库的蛋白质-蛋白质相互作用分析获得了8个可与ZWINT相互作用的顶级基因,包括 、 、 、 、 、 、 、 。
ZWINT在肺肿瘤组织中异常高表达,可能参与肺癌的发病机制。